DrugCard
Description
DrugCard, a groundbreaking tool enhances the safety of medicines by using advanced technology to gather critical safety information. Our tool scans over 1000 medical journals in 100 different languages, looking for mentions of drug safety issues like side effects or adverse reactions, and collects this data quickly and accurately.
The core of our innovation is a blend of OCR, parsers, crawlers and AI. These technologies allow us to read and analyze both online and printed medical journals, ensuring we find all mentions of drugs and safety information. This comprehensive approach helps identify potential safety issues that others might miss, contributing to better patient safety.
One of the standout features of our system is its efficiency. Traditional methods of reviewing medical journals are slow and require a lot of manual effort, often taking weeks or months. Our tool performs this task much faster, making the process eight times more efficient. This speed enables pharmaceutical companies to obtain crucial safety information quickly, helping them respond to issues more effectively.
We also provide a high degree of customization for our clients. If a pharmaceutical company needs to monitor specific journals or countries, we can add these to our system within two weeks, significantly faster than the industry standard of six months. This flexibility ensures our clients always have access to the latest and most relevant information.
BASIC INFORMATION
DrugCard has quickly become a key player in one of the most conservative industries in the world: pharmaceuticals. Within just two years, we have expanded to 14 EU countries, including Poland, partnering with major companies like Adamed, Polpharma, and Biofarm. Our innovative SaaS solution revolutionizes pharmacovigilance by automating literature screening, which drastically reduces the time and effort required for compliance.
We manage the largest database of local journals in various languages, offering unmatched coverage and accuracy. Our proprietary technology, combining OCR, parsers, and crawlers, processes both online and hard copy journals, identifying more drug mentions than any competitor. We also offer the unique capability to add custom journals and countries in just two weeks, compared to the six months it takes others.
Our solution not only meets but exceeds EU regulatory requirements, ensuring precise and reliable drug safety information. By leveraging cutting-edge technology, DrugCard transforms drug safety, providing deeper insights and greater efficiency. Our services cover drug safety data collection from 50 countries, supporting our clients in maintaining stringent regulatory compliance and enhancing patient safety.
